BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 24095000)

  • 1. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to access for Canadians who use cannabis for therapeutic purposes.
    Belle-Isle L; Walsh Z; Callaway R; Lucas P; Capler R; Kay R; Holtzman S
    Int J Drug Policy; 2014 Jul; 25(4):691-9. PubMed ID: 24947993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada.
    Capler R; Walsh Z; Crosby K; Belle-Isle L; Holtzman S; Lucas P; Callaway R
    Int J Drug Policy; 2017 Sep; 47():1-8. PubMed ID: 28667878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.
    Hakkarainen P; Frank VA; Barratt MJ; Dahl HV; Decorte T; Karjalainen K; Lenton S; Potter G; Werse B
    Int J Drug Policy; 2015 Mar; 26(3):250-6. PubMed ID: 25123694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
    Bonn-Miller MO; Boden MT; Bucossi MM; Babson KA
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):23-30. PubMed ID: 24205805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to access to medical cannabis for Canadians living with HIV/AIDS.
    Belle-Isle L; Hathaway A
    AIDS Care; 2007 Apr; 19(4):500-6. PubMed ID: 17453590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical cannabis: US researchers battle for access to the plant.
    Frisch S
    BMJ; 2014 Nov; 349():g6997. PubMed ID: 25416312
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.
    Lucas P; Walsh Z
    Int J Drug Policy; 2017 Apr; 42():30-35. PubMed ID: 28189912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.
    Wadsworth E; Leos-Toro C; Hammond D
    Subst Use Misuse; 2020; 55(4):582-589. PubMed ID: 31747851
    [No Abstract]   [Full Text] [Related]  

  • 10. Cannabis Enthusiasts' Knowledge of Medical Treatment Effectiveness and Increased Risks From Cannabis Use.
    Kruger DJ; Kruger JS; Collins RL
    Am J Health Promot; 2020 May; 34(4):436-439. PubMed ID: 31916839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for therapeutic purposes and public health and safety: a systematic and critical review.
    Sznitman SR; Zolotov Y
    Int J Drug Policy; 2015 Jan; 26(1):20-9. PubMed ID: 25304050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations.
    Penn RA
    Int J Drug Policy; 2014 May; 25(3):372-7. PubMed ID: 24439711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
    Leos-Toro C; Shiplo S; Hammond D
    Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis for medical purposes: dynamic surrounding conditions - appropriate information].
    Cremer-Schaeffer P; Knöss W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):799-800. PubMed ID: 31201444
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabis education needs assessment among Canadian physicians-in-training.
    St Pierre M; Matthews L; Walsh Z
    Complement Ther Med; 2020 Mar; 49():102328. PubMed ID: 32147035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring medicinal use of cannabis in a time of policy change in New Zealand.
    Rychert M; Wilkins C; Parker K; Graydon-Guy T
    N Z Med J; 2020 May; 133(1515):54-69. PubMed ID: 32438377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience.
    Waissengrin B; Urban D; Leshem Y; Garty M; Wolf I
    J Pain Symptom Manage; 2015 Feb; 49(2):223-30. PubMed ID: 24937161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.